<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVES: It has been shown that <z:mpath ids='MPATH_127'>atrophy</z:mpath> of medial temporal lobe structures such as the hippocampus and entorhinal cortex shown on MRI may distinguish patients with <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> from healthy controls </plain></SENT>
<SENT sid="1" pm="."><plain>However, the diagnostic value of visual inspection and volumetry of medial temporal lobe <z:mpath ids='MPATH_127'>atrophy</z:mpath> (MTA) on MRI in a clinical setting is insufficiently known </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Medial temporal lobe <z:mpath ids='MPATH_127'>atrophy</z:mpath> in 143 patients was visually rated from hard copies, using a 0-4 rating scale and a comparison was made with the volumes (cm(3)) of the medial temporal lobe as estimated with volumetry, using a stereological method </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients were recruited in an unselected way in a clinical setting in the centre for <z:hpo ids='HP_0002354'>memory impairments</z:hpo> at the Huddinge University Hospital </plain></SENT>
<SENT sid="4" pm="."><plain>Patients with <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> (n=41), patients with other <z:hpo ids='HP_0000726'>dementias</z:hpo> (vascular <z:hpo ids='HP_0000726'>dementia</z:hpo>, <z:hpo ids='HP_0002145'>frontotemporal dementia</z:hpo>, and unspecified <z:hpo ids='HP_0000726'>dementia</z:hpo>; n=36) as well as non-<z:e sem="disease" ids="C0860630" disease_type="Mental or Behavioral Dysfunction" abbrv="">demented</z:e> subjects (n=66) were included </plain></SENT>
<SENT sid="5" pm="."><plain>Medial temporal <z:mpath ids='MPATH_127'>atrophy</z:mpath> and volumetry were evaluated as a diagnostic tool by performing logistic regression analysis including age, sex, and mini mental state examination (MMSE) score and calculating the sensitivity and specificity and percentage correct classification </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Visual and volumetric analysis yielded statistically significant differences between patients with <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> and non-<z:e sem="disease" ids="C0860630" disease_type="Mental or Behavioral Dysfunction" abbrv="">demented</z:e> subjects, as well as between those with other <z:hpo ids='HP_0000726'>dementias</z:hpo> and non-<z:e sem="disease" ids="C0860630" disease_type="Mental or Behavioral Dysfunction" abbrv="">demented</z:e> subjects </plain></SENT>
<SENT sid="7" pm="."><plain>Combining MMSE scores and visually rated MTA ratings yielded a sensitivity of 95% for <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e>, 85% for other <z:hpo ids='HP_0000726'>dementias</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>Non-<z:e sem="disease" ids="C0860630" disease_type="Mental or Behavioral Dysfunction" abbrv="">demented</z:e> subjects were identified with a specificity of 96% </plain></SENT>
<SENT sid="9" pm="."><plain>Volumetry did not have an added value over the MMSE score alone </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: Visual rating of MTA is a clinically useful method for differentiating <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> from controls and is both quicker and more accurate than volumetry </plain></SENT>
</text></document>